다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Current neuropharmacology, v.7 no.4, 2009년, pp.269 - 275
Dong, Xue (Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, No. 44 WenHuaXi Road, Jinan 250012, P.R. China) , Song, Yu-Ning (Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, No. 44 WenHuaXi Road, Jinan 250012, P.R. China) , Liu, Wei-Guo (Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, No. 44 WenHuaXi Road, Jinan 250012, P.R. China) , Guo, Xiu-Li (Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, No. 44 WenHuaXi Road, Jinan 250012, P.R. China)
AI-Helper
Matrix metalloproteinase-9 (MMP-9) which is a member of matrix metalloproteinases family that normally remodel the extracellular matrix, has been shown to play an important role in both animal models of cerebral ischemia and human stroke. The expression of MMP-9 is elevated after cerebral ischemia w...
1 Asahi M Asahi K Jung JC del Zoppo GJ Fini ME Lo EH Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94 J. Cereb. Blood Flow Metab 2000 20 1681 1689 11129784
2 Asahi M Wang X Mori T Sumii T Jung JC Moskowitz MA Fini ME Lo EH Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia J. Neurosci 2001 21 7724 7732 11567062
3 Burggraf D Trinkl A Dichgans M Hamann GF Doxycycline inhibits MMPs via modulation of plasminogen activators in focal cerebral ischemia Neurobiol. Dis 2007 25 506 513 17166729
4 Busti C Falcinelli E Momi S Gresele P Matrix metalloproteinases and peripheral arterial disease Intern. Emerg Med 2009 Sep 24 [Epub ahead of print]
5 Candelario-Jalil E Yang Y Rosenberg GA Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia Neuroscience 2009 158 983 994 18621108
6 Candelario-Jalil E Nimesulide as a promising neuroprotectant in brain ischemia: New experimental evidences Pharmacol. Res 2008 57 266 273 18439837
7 Candelario-Jalil E Taheri S Yang Y Sood R Grossetete M Estrada EY Fiebich BL Rosenberg GA Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat J. Pharmacol. Exp. Ther 2007 323 488 498 17704356
8 Castellanos M Leira R Serena J Pumar JM Lizasoain I Castillo J Dávalos A Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke Stroke 2003 34 40 46 12511748
9 Chakraborti S Mandal M Das S Mandal A Chakraborti T Regulation of matrix metalloproteinases: An overview Mol. Cell. Biochem 2003 253 269 285 14619979
10 Cho JY Kim IS Jang YH Kim AR Lee SR Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia Neurosci. Lett 2006 404 330 335 16806698
11 Copin JC Merlani P Sugawara T Chan PH Gasche Y Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats Exp. Neurol 2008 213 196 201 18590727
12 Coussens LM Tinkle CL Hanahan D Werb Z MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 2000 103 481 490 11081634
13 Dzwonek J Rylski M Kaczmarek L Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain FEBS. Lett 2004 567 129 135 15165905
14 Ellerbroek SM Halbleib JM Benavidez M Warmka JK Wattenberg EV Stack MS Hudson LG Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association Cancer Res 2001 61 1855 1861 11280738
15 Fingleton B Matrix metalloproteinases as valid clinical targets Curr. Pharm. Des 2007 13 333 346 17313364
16 Föerster C Kahles T Kietz S Drenckhahn D Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND J. Physiol 2007 580 937 949 17317742
17 Gao D Zhang X Jiang X Peng Y Huang W Cheng G Song L Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice Life Sci 2006 78 2564 2570 16321402
18 Gasche Y Fujimura M Morita-Fujimura Y Copin JC Kawase M Massengale J Chan PH Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction J. Cereb. Blood Flow Metab 1999 19 1020 1028 10478654
19 Gidday JM Gasche YG Copin JC Shah AR Perez RS Shapiro SD Chan PH Park TS Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia Am. J. Physiol. Heart Circ. Physiol 2005 289 H558 H568 15764676
20 Gómez-Hernández A Sánchez-Galán E Ortego M Martín-Ventura JL Blanco-Colio LM Tarín-Vicente N Jiménez-Nacher JJ López-Bescos L Egido J Tuñón J Effect of intensive Atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome Am. J. Cardiol 2008 102 12 18 18572029
21 Gu Z Kaul M Yan B Kridel SL Cui J Strongin A Smith JW Liddington RC Lipton SA S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death Science 2002 297 1186 1190 12183632
22 Guo RW Yang LX Wang H Liu B Wang L Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB- dependent pathway in vascular smooth muscle cells Regul. Pept 2008 147 37 44 18252266
23 Gurney KJ Estrada EY Rosenberg GA Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation Neurobiol. Dis 2006 23 87 96 16624562
24 Haddad M Beray-Berthat V Cogueran B Palmier B Szabo C Plotkine M Margaill I Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice Eur. J. Pharmacol 2008 588 52 57 18468597
25 Ho TY Bagnell CA Sherwood OD Fields PA Steintz BG Relaxin induces matrix metalloproteinase-9 through activation of nuclear factor kappa B in human THP-1 cells 4th International Conference on Relaxin and Related Peptides 2004 4th Moran WY 314 316
26 Horstmann S Kalb P Koziol J Gardner H Wagner S Profiles of mtrix metalloproteinases, their inhibitors, and laminin in stroke patients- Influence of different therapies Stroke 2003 34 2165 2170 12907822
27 Hosomi N Mizushige K Kitadai M Ohyama H Ichihara SI Takahashi T Matsuo H Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia Brain Res 1999 835 188 196 10415373
28 Hosomi N Nishiyama A Ban CR Naya T Takahashi T Kohno M Koziol JA Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia Neuroscience 2005 134 225 231 15963646
29 Jiang X Namura S Nagata I Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice Neurosci. Lett 2001 305 41 44 11356303
30 Lee H Park JW Kim SP Lo EH Lee SR Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia Neurobiol. Dis 2009 34 189 198 19200854
31 Lee SR Kim HY Rogowska J Zhao BQ Bhide P Parent JM Lo EH Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke J. Neurosci 2006 26 3491 3495 16571756
32 Liebetrau M Burggraf D Wunderlich N Jäger G Linz W Hamann GF ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats Neurosci. Lett 2005 376 205 209 15721222
33 Liu JF Crépin M Liu JM Barritault D Ledoux D FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway Biochem. Bioph. Res. Commun 2002 293 1174 1182
34 Liu R Wen Y Perez E Wang X Day AL Simpkins JW Yang SH 17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female Brain Res 2005 1060 55 61 16212944
35 Lo EH A new penumbra: transitioning from injury into repair after stroke Nat. Med 2008 14 497 500 18463660
36 Ma Z Shah RC Chang MJ Benveniste EN Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription Mol. Cell. Biol 2004 24 5496 5509 15169910
37 Machado LS Kozak A Ergul A Hess DC Borlongan CV Fagan SC Delayed minocycline inhibits ischemia-activated matrix metalloprotein- ases 2 and 9 after experimental stroke BMC Neurosci 2006 7 56 16846501
38 Magnoni S Baker A Thomson S Jordan G George SJ McColl BW McCulloch J Horsburgh K Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and-2 in ischemic brain injury Gene Ther 2007 14 621 625 17235293
39 Manabe S Gu Z Lipon SA Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death Invest. Ophthalmol. Vis. Sci 2005 46 4747 4753 16303975
40 Montaner J Alvarez-Sabín J Molina C Anglés A Abilleira S Arenillas J González MA Monasterio J Matrix metalloproteinase expression after human cardioembolic stroke - Temporal profile and relation to neurological impairment Stroke 2001 32 1759 1766 11486102
41 Montaner J Alvarez-Sabín J Molina CA Anglés A Abilleira S Arenillas J Monasterio J Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke Stroke 2001 32 2762 2767 11739970
42 Montaner J Molina CA Monasterio J Abilleira S Arenillas JF Ribó M Quintana M Alvarez-Sabín J Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke Circulation 2003 107 598 603 12566373
43 Montaner J Rovira A Molina CA Arenillas JF Ribó M Chacón P Monasterio J Alvarez-Sabín J Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke J. Cereb. Blood Flow Metab 2003 23 1403 1407 14663335
44 Murono S Yoshizaki T Sato H Takeshita H Furukawa M Pagano JS Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression Cancer Res 2000 60 2555 2561 10811139
45 Murphy G Nagase H Progress in matrix metalloproteinase research Mol. Aspects Med 2008 29 290 308 18619669
46 Nagel S Su Y Horstmann S Heiland S Gardner H Koziol J Martinez-Torres FJ Wagner S Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat - Effects on BBB breakdown and MMP expression in the acute and subacute phase Brain Res 2008 1188 198 206 18031717
47 Ospina JA Brevig HN Krause DN Duckles SP Estrogen suppresses IL-1 beta-mediated induction of COX-2 pathway in rat cerebral blood vessels Am. J. Physiol. Heart Circ. Physiol 2004 286 H2010 H2019 14684367
48 Park KP Rosell A Foerch C Xing C Kim WJ Lee S Opdenakker G Furie KL Lo EH Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in Rats Stroke 2009 40 2836 2842 19556529
49 Pfefferkorn T Rosenberg GA Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion Stroke 2003 34 2025 2030 12855824
50 Planas AM Solé S Justicia C Expression and activation of matrix metalloproteinase-2 and-9 in rat brain after transient focal cerebral ischemia Neurobiol. Dis 2001 8 834 846 11592852
51 Ruhul Amin AR Senga T Oo ML Thant AA Hamaguchi M Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1 beta: a role for the dual signalling pathways, Akt and Erk Genes Cells 2003 8 515 523 12786942
52 Romanic AM White RF Arleth AJ Ohlstein EH Barone FC Matrix metalloproteinase expression increases after cerebral focal ischemia in rats - Inhibition of matrix metalloproteinase-9 reduces infarct size Stroke 1998 29 1020 1030 9596253
53 Rosell A Cuadrado E Ortega-Aznar A Hernández-Guillamon M Lo EH Montaner J MMP-9-Positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke Stroke 2008 39 1121 1126 18323498
54 Rosell A Lo EH Multiphasic roles for matrix metalloproteinases after stroke Curr. Opin. Pharmacol 2008 8 82 89 18226583
55 Rosell A Ortega-Aznar A Alvarez-Sabín J Fernández-Cadenas I Ribó M Molina CA Lo EH Montaner J Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke Stroke 2006 37 1399 1406 16690896
56 Rosenberg GA Matrix metalloproteinases in neuroinflammation Glia 2002 39 279 291 12203394
57 Rosenberg A Matrix metalloproteinases and their multiple roles in neurodegenerative diseases Lancet Neurol 2009 8 205 216 19161911
58 Rosenberg GA Estrada EY Dencoff JE Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain Stroke 1998 29 2189 2195 9756602
59 Rush TS 3rd Powers R The application of X-ray, NMR, and molecular modeling in the design of MMP inhibitors Curr. Top. Med. Chem 2004 4 1311 1327 15320728
60 Solé S Petegnief V Gorina R Chamorro A Planas AM Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion J. Neuropathol. Exp. Neurol 2004 63 338 349 15099024
61 Sun JT Feng A Zhang Y Sun SZ Hu WX Yang MX Wei FC Qu X Fucoidan increases TNF-a-induced MMP-9 secretion in monocytic cell line U937 Inflamm. Res. 2009 9 23 [Epub ahead of print]
62 Suyama K Shapiro I Guttman M Hazan RB A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor Cancer Cell 2002 2 301 314 12398894
63 Tanaka H Takai S Jin D Furubayashi K Inoue N Kajimoto Y Miyatake S Kuroiwa T Miyazaki M Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats Hypertens. Res 2007 30 469 475 17587759
64 Tsubokawa T Solaroglu I Yatsushige H Cahill J Yata K Zhang JH Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats Stroke 2006 37 1888 1894 16763180
65 Tziakas DN Chalikias GK Parissis JT Hatzinikolaou EI Papadopoulos ED Tripsiannis GA Papadopoulou EG Tentes IK Karas SM Chatseras DI Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration Int. J. Cardiol 2004 94 269 277 15093992
66 Van den Steen PE Van Aelst I Hvidberg V Piccard H Fiten P Jacobsen C Moestrup SK Fry S Royle L Wormald MR Wallis R Rudd PM Dwek RA Opdenakker G The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors J. Biol. Chem 2006 281 18626 18637 16672230
67 Wang GM Guo QM Hossain M Fazio V Zeynalov E Janigro D Mayberg MR Namura S Bone marrow-derived cells are the major source of MMP-9 contributing to blood–brain barrier dysfunction and infarct formation after ischemic stroke in mice Brain Res 2009 1294 183 192 19646426
68 Wang Y Deng XL Xiao XH Yuan BX A non-steroidal anti-inflammatory agent provides significant protection during focal ischemic stroke with decreased expression of matrix metalloproteinases Curr. Neurovasc. Res 2007 4 176 183 17691971
69 Woo JH Lim JH Kim YH Suh SI Min DS Chang JS Lee YH Park JW Kwon TK Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction Oncogene 2004 23 1845 1853 14661062
70 Xu Z Zhao S Zhou H Ye H Li J Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome Clin. Chem 2004 50 750 753 15044331
71 Zhang XJ Wang Y Yamamoto G Tachikawa T Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas Histopathology 2009 55 250 260 19723139
72 Zhao BQ Ikeda Y Ihara H Urano T Fan W Mikawa S Suzuki Y Kondo K Sato K Nagai N Umemura K Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice Blood 2004 103 2610 2616 14630814
73 Zhao BQ Tejima E Lo EH Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. 25th Princeton Conference on Cerebrovascular Disease Portland, OR 2006 pp. 748 752
74 Zhao BQ Wang S Kim HY Storrie H Rosen BR Mooney DJ Wang XY Lo EH Role of matrix metalloproteinases in delayed cortical responses after stroke Nat. Med 2006 12 441 445 16565723
75 Zhao X Benveniste EN Transcriptional Activation of human matrix metalloproteinase-9 gene expression by multiple Co-activators J. Mol. Biol 2008 383 945 956 18790699
76 Zheng YQ Liu JX Wang JN Xu L Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia Brain Res 2007 1138 86 94 17274961
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.